U.S. FDA Approves NEXTSTELLIS®, New Oral Contraceptive ...Middle East

PR Newswire - News
U.S. FDA Approves NEXTSTELLIS®, New Oral Contraceptive
GREENVILLE, N.C., April 16, 2021 /PRNewswire/ -- Mayne Pharma announced today that the U.S. Food and Drug Administration (FDA) has approved NEXTSTELLIS (3 mg drospirenone [DRSP] and 14.2 mg estetrol [E4] tablets) for the prevention of pregnancy. NEXTSTELLIS is the first and only...

Hence then, the article about u s fda approves nextstellis new oral contraceptive was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( U.S. FDA Approves NEXTSTELLIS®, New Oral Contraceptive )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News